Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial

In an early-stage randomized trial, the safety and efficacy of intramyocardial injection of hiPSC-derived cardiomyocytes in patients with advanced heart failure were evaluated.



